Patterns and correlates of patient-reported helpfulness of treatment for common mental and substance use disorders in the WHO World Mental Health Surveys.

Helpfulness of treatment anxiety disorders heterogeneity of treatment effects mood disorders patient-centered care post-traumatic stress disorder precision psychiatry professional help-seeking substance use disorders treatment adher­ence

Journal

World psychiatry : official journal of the World Psychiatric Association (WPA)
ISSN: 1723-8617
Titre abrégé: World Psychiatry
Pays: Italy
ID NLM: 101189643

Informations de publication

Date de publication:
Jun 2022
Historique:
entrez: 7 5 2022
pubmed: 8 5 2022
medline: 8 5 2022
Statut: ppublish

Résumé

Patient-reported helpfulness of treatment is an important indicator of quality in patient-centered care. We examined its pathways and predictors among respondents to household surveys who reported ever receiving treatment for major depression, generalized anxiety disorder, social phobia, specific phobia, post-traumatic stress disorder, bipolar disorder, or alcohol use disorder. Data came from 30 community epidemiological surveys - 17 in high-income countries (HICs) and 13 in low- and middle-income countries (LMICs) - carried out as part of the World Health Organization (WHO)'s World Mental Health (WMH) Surveys. Respondents were asked whether treatment of each disorder was ever helpful and, if so, the number of professionals seen before receiving helpful treatment. Across all surveys and diagnostic categories, 26.1% of patients (N=10,035) reported being helped by the very first professional they saw. Persisting to a second professional after a first unhelpful treatment brought the cumulative probability of receiving helpful treatment to 51.2%. If patients persisted with up through eight professionals, the cumulative probability rose to 90.6%. However, only an estimated 22.8% of patients would have persisted in seeing these many professionals after repeatedly receiving treatments they considered not helpful. Although the proportion of individuals with disorders who sought treatment was higher and they were more persistent in HICs than LMICs, proportional helpfulness among treated cases was no different between HICs and LMICs. A wide range of predictors of perceived treatment helpfulness were found, some of them consistent across diagnostic categories and others unique to specific disorders. These results provide novel information about patient evaluations of treatment across diagnoses and countries varying in income level, and suggest that a critical issue in improving the quality of care for mental disorders should be fostering persistence in professional help-seeking if earlier treatments are not helpful.

Identifiants

pubmed: 35524618
doi: 10.1002/wps.20971
pmc: PMC9077614
doi:

Types de publication

Journal Article

Langues

eng

Pagination

272-286

Informations de copyright

© 2022 World Psychiatric Association.

Références

World Psychiatry. 2021 Feb;20(1):34-51
pubmed: 33432742
Bipolar Disord. 2020 Aug;22(5):440-460
pubmed: 32356562
PLoS One. 2017 Apr 10;12(4):e0175383
pubmed: 28394905
BMC Psychiatry. 2012 Jul 24;12:87
pubmed: 22828119
J Affect Disord. 2021 Jun 1;288:199-209
pubmed: 33940429
BMC Med. 2017 Apr 13;15(1):80
pubmed: 28403846
World Psychiatry. 2021 Jun;20(2):154-170
pubmed: 34002503
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Bipolar Disord. 2021 Sep;23(6):565-583
pubmed: 33638300
Soc Psychiatry Psychiatr Epidemiol. 2022 Mar 9;:
pubmed: 35262761
Int J Methods Psychiatr Res. 2004;13(2):122-39
pubmed: 15297907
Curr Opin Psychiatry. 2018 Jan;31(1):32-39
pubmed: 29076894
World Psychiatry. 2021 Oct;20(3):336-356
pubmed: 34505377
Br J Psychiatry. 2013 Jan;202(1):42-9
pubmed: 23174514
World Psychiatry. 2021 Feb;20(1):4-33
pubmed: 33432763
BMC Psychiatry. 2021 Aug 9;21(1):392
pubmed: 34372811
Br J Psychiatry. 2010 Nov;197(5):378-85
pubmed: 21037215
Drug Alcohol Depend. 2021 Dec 1;229(Pt B):109158
pubmed: 34784556
Community Ment Health J. 2021 Jul;57(5):836-852
pubmed: 32285371
JAMA Psychiatry. 2020 Aug 1;77(8):830-841
pubmed: 32432716
Epidemiol Psychiatr Sci. 2020 Aug 18;29:e161
pubmed: 32807256
Cochrane Database Syst Rev. 2017 Jan 06;1:CD007906
pubmed: 28067944
Depress Anxiety. 2020 Oct;37(10):972-994
pubmed: 32667096
World Psychiatry. 2020 Oct;19(3):269-293
pubmed: 32931110
Int J Methods Psychiatr Res. 2004;13(2):93-121
pubmed: 15297906
Lancet Psychiatry. 2016 May;3(5):415-24
pubmed: 27083119
Int J Epidemiol. 2014 Apr;43(2):476-93
pubmed: 24648481
Mol Psychiatry. 2020 Jul;25(7):1487-1499
pubmed: 31745237
Eur J Psychotraumatol. 2021 Dec 9;12(1):2002028
pubmed: 34912502
Front Psychol. 2020 Jul 30;11:1759
pubmed: 32849042
JAMA Psychiatry. 2021 Dec 1;78(12):1384-1390
pubmed: 34550327
J Med Internet Res. 2019 Jun 18;21(6):e12505
pubmed: 31215517
JAMA Psychiatry. 2020 Aug 1;77(8):784-786
pubmed: 32432693

Auteurs

Ronald C Kessler (RC)

Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.

Alan E Kazdin (AE)

Department of Psychology, Yale University, New Haven, CT, USA.

Sergio Aguilar-Gaxiola (S)

Center for Reducing Health Disparities, UC Davis Health System, Sacramento, CA, USA.

Ali Al-Hamzawi (A)

College of Medicine, Al-Qadisiya University, Diwaniya Governorate, Iraq.

Jordi Alonso (J)

Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain.

Yasmin A Altwaijri (YA)

Epidemiology Section, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Laura H Andrade (LH)

Núcleo de Epidemiologia Psiquiátrica - LIM 23, Instituto de Psiquiatria Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Corina Benjet (C)

Department of Epidemiologic and Psychosocial Research, National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.

Chrianna Bharat (C)

National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia.

Guilherme Borges (G)

Department of Epidemiologic and Psychosocial Research, National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.

Ronny Bruffaerts (R)

Universitair Psychiatrisch Centrum - Katholieke Universiteit Leuven, Leuven, Belgium.

Brendan Bunting (B)

School of Psychology, Ulster University, Londonderry, UK.

José Miguel Caldas de Almeida (JMC)

Lisbon Institute of Global Mental Health and Chronic Diseases Research Center, NOVA University of Lisbon, Lisbon, Portugal.

Graça Cardoso (G)

Lisbon Institute of Global Mental Health and Chronic Diseases Research Center, NOVA University of Lisbon, Lisbon, Portugal.

Wai Tat Chiu (WT)

Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.

Alfredo Cía (A)

Anxiety Disorders Research Center, Buenos Aires, Argentina.

Marius Ciutan (M)

National School of Public Health, Management and Professional Development, Bucharest, Romania.

Louisa Degenhardt (L)

National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia.

Giovanni de Girolamo (G)

IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.

Peter de Jonge (P)

Department of Developmental Psychology, University of Groningen, Groningen, The Netherlands.

Ymkje Anna de Vries (YA)

Department of Developmental Psychology, University of Groningen, Groningen, The Netherlands.

Silvia Florescu (S)

National School of Public Health, Management and Professional Development, Bucharest, Romania.

Oye Gureje (O)

Department of Psychiatry, University College Hospital, Ibadan, Nigeria.

Josep Maria Haro (JM)

Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain.

Meredith G Harris (MG)

School of Public Health, University of Queensland, Herston, and Queensland Centre for Mental Health Research, Wacol, QLD, Australia.

Chiyi Hu (C)

Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Shenzhen, China.

Aimee N Karam (AN)

Institute for Development, Research, Advocacy and Applied Care, Beirut, Lebanon.

Elie G Karam (EG)

Institute for Development, Research, Advocacy and Applied Care, Beirut, Lebanon.
Department of Psychiatry and Clinical Psychology, St. George Hospital University Medical Center, Beirut, Lebanon.

Georges Karam (G)

Institute for Development, Research, Advocacy and Applied Care, Beirut, Lebanon.
Department of Psychiatry and Clinical Psychology, St. George Hospital University Medical Center, Beirut, Lebanon.

Norito Kawakami (N)

Department of Mental Health, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

Andrzej Kiejna (A)

Psychology Research Unit for Public Health, WSB University, Torun, Poland.

Viviane Kovess-Masfety (V)

Laboratoire de Psychopathologie et Processus de Santé EA 4057, Université de Paris, Paris, France.

Sing Lee (S)

Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong.

Victor Makanjuola (V)

Department of Psychiatry, University College Hospital, Ibadan, Nigeria.

John J McGrath (JJ)

School of Public Health, University of Queensland, Herston, and Queensland Centre for Mental Health Research, Wacol, QLD, Australia.
National Centre for Register-based Research, Aarhus University, Aarhus, Denmark.

Maria Elena Medina-Mora (ME)

Department of Epidemiologic and Psychosocial Research, National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.

Jacek Moskalewicz (J)

Institute of Psychiatry and Neurology, Warsaw, Poland.

Fernando Navarro-Mateu (F)

Unidad de Docencia, Investigación y Formación en Salud Mental, Universidad de Murcia, Murcia, Spain.

Andrew A Nierenberg (AA)

Dauten Family Center for Bipolar Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.

Daisuke Nishi (D)

Department of Mental Health, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

Akin Ojagbemi (A)

Department of Psychiatry, University College Hospital, Ibadan, Nigeria.

Bibilola D Oladeji (BD)

Department of Psychiatry, University College Hospital, Ibadan, Nigeria.

Siobhan O'Neill (S)

School of Psychology, Ulster University, Londonderry, UK.

José Posada-Villa (J)

Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia.

Victor Puac-Polanco (V)

Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.

Charlene Rapsey (C)

Department of Psychological Medicine, University of Otago, Dunedin, New Zealand.

Ayelet Meron Ruscio (AM)

Department of Psychology, University of Pennsylvania, Philadelphia, PA, USA.

Nancy A Sampson (NA)

Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.

Kate M Scott (KM)

Department of Psychological Medicine, University of Otago, Dunedin, New Zealand.

Tim Slade (T)

Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, Australia.

Juan Carlos Stagnaro (JC)

Departamento de Psiquiatría y Salud Mental, Universidad de Buenos Aires, Buenos Aires, Argentina.

Dan J Stein (DJ)

Department of Psychiatry & Mental Health and South African Medical Council Research Unit on Risk and Resilience in Mental Disorders, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.

Hisateru Tachimori (H)

National Institute of Mental Health, National Center for Neurology and Psychiatry, Kodaira, Tokyo, Japan.

Margreet Ten Have (M)

Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands.

Yolanda Torres (Y)

Center for Excellence on Research in Mental Health, CES University, Medellin, Colombia.

Maria Carmen Viana (MC)

Department of Social Medicine, Postgraduate Program in Public Health, Federal University of Espírito Santo, Vitoria, Brazil.

Daniel V Vigo (DV)

Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.
Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.

David R Williams (DR)

Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Bogdan Wojtyniak (B)

Centre of Monitoring and Analyses of Population Health, National Institute of Public Health - National Research Institute, Warsaw, Poland.

Miguel Xavier (M)

Lisbon Institute of Global Mental Health and Chronic Diseases Research Center, NOVA University of Lisbon, Lisbon, Portugal.

Zahari Zarkov (Z)

Department of Mental Health, National Center of Public Health and Analyses, Sofia, Bulgaria.

Hannah N Ziobrowski (HN)

Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.

Classifications MeSH